Clinical Trial

Pilot Study of MC in Paediatric Palliative Care

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The goal of this pilot study is to explore the feasibility and acceptability of a medicinal cannabis clinical trial into easing the symptoms of children undergoing palliative care for non-oncological conditions. The trial will evaluate the study design including recruitment strategy, medication tolerability, duration and outcomes to determine acceptability and feasibility for participating families. The data collected will then be used to design a full-scale multi-centre trial. Participants will be randomly allocated to receive one of two medicinal cannabis products. Neither the participants nor researchers will know the study drug allocation until the end of the trial.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-11-07; most recent amendment 2025-12-17.
Status change: Not Yet Recruiting → Recruiting 2024-03-11
Trial Details
NCT Number NCT05615389
Lead Sponsor Murdoch Childrens Research Institute
Conditions Palliative Care
Enrollment 10 participants
Start Date 2024-02-19
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-24